483
Piedmont Reproductive Endocrinology Group, PaFDA 483 - Piedmont Reproductive Endocrinology Group, Pa - January 21, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Piedmont Reproductive Endocrinology Group, Pa in Greenville, SC was inspected by the FDA from January 16-21, 2026. The inspection revealed a significant issue regarding donor screening procedures for anonymous oocyte donors. The firm failed to perform complete physical examinations within the required six-month timeframe, instead using abbreviated screening methods, which led to the use of oocytes from inadequately screened donors.
- Inspection Date
- January 21, 2026
- Product Type
- Biologics
Open in Dashboard
ID · 39d5c76d-2a01-4481-a76d-88010c12d2fb